Drawing for SOLESIS

USPTO serial 90884552

SOLESIS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BECKER, JOSEPH RAPHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOLESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian P. Gregg

Brian P. Gregg MCNEES WALLACE & NURICK100 PINE STREETHARRISBURG, PA 17108United States

Goods and services

ClassDescriptionStatusFirst use
005Combination natural biologic and artificial materials consisting primarily of biological materials sold as an integral component of surgical implants, pharmaceutical preparations, and biomanufacturing preparations for medical purposes, namely, implantable medical textiles, polymeric textiles, implantable polymers, and polymeric biocontainment systems composed of natural and artificial biomaterialsACTIVE—
010Artificial materials sold as an integral component of surgical implantsACTIVE—
042Research, design and development services in the field of medical devices, pharmaceuticals, and biological therapeutics; design and development of medical devices, pharmaceuticals, and biomanufacturing products and their manufacturing methods; Product quality testing, namely, medical device, pharmaceutical, and biomanufacturing product evaluation services; Research for and design and development of new medical devices, pharmaceuticals, and biological therapeutics for others; Medical research in the field of synthetic implants; Medical research relating to synthetic tissue; Medical research in the field of controlled release; Medical research relating to pharmaceutical delivery; Medical research related to biologically derived therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 9, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 9, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2025EX5GSOU EXTENSION 5 GRANTED—
Dec 15, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2025EXT5SOU EXTENSION 5 FILED—
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 14, 2025EX4GSOU EXTENSION 4 GRANTED—
Jan 14, 2025EXT4SOU EXTENSION 4 FILED—
Jan 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2024EX3GSOU EXTENSION 3 GRANTED—
Jul 29, 2024EXT3SOU EXTENSION 3 FILED—
Jul 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2024EX2GSOU EXTENSION 2 GRANTED—
Jan 29, 2024EXT2SOU EXTENSION 2 FILED—
Jan 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 6, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2023EX1GSOU EXTENSION 1 GRANTED—
Jun 2, 2023EXT1SOU EXTENSION 1 FILED—
Jun 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 4, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Nov 4, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 4, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 4, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 3, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2022DOCKASSIGNED TO EXAMINER—
Oct 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 19, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance